Particularly useful information on the characteristics of each coronavirus vaccine, licensed by the European Medicines Agency (EMA) was made public by the Ministry of Health of Cyprus.
The vaccines against COVID-19 who have received the "green light" from the European Medicines Agency (EMA) are the: Pfizer/BioNTech, AstraZeneca, Moderna and Johnson & Johnson.
How long it takes between the 1st and 2nd dose per vaccine
Pfizer/BioNTech: The Pfizer / BioNTech vaccine is given in two doses with a time difference 3 weeks between them.
AstraZeneca: The AstraZeneca vaccine is given in two divided doses 8 weeks between them.
Modern: The Moderna vaccine is given in two divided doses 28 days between them.
Johnson & Johnson: The Johnson vaccine&Johnson is given in a single dose and whoever receives it completes their vaccination regimen.
Percentage of protection after each dose per vaccine
According to the official data that have emerged from the clinical studies but also from the official announcements of the companies, The immunity offered by coronavirus vaccines after each dose is as follows:
Pfizer/BioNTech: offers immunity 52% seven days after the 1st dose, with the percentage increasing to 89% after another week. According to the latest data from Pfizer, seven days after the 2nd dose, the efficiency reaches 91,3% against mild COVID-19 and 95,3% versus serious.
AstraZeneca: ensures immunity against 70% three weeks after the first dose, while 15 days after the 2nd dose protection against COVID-19 of the order is achieved 76% to 94% and it is 100% effective in preventing serious illness and hospitalization.
Modern: the efficiency reaches 92% 14 days after the 1st dose, while 14 days from the 2nd dose, efficiency reaches 94,1%, while protection six (6) months after the 2nd dose amounts to 90% against mild COVID-19 disease and in 95% for serious.
Johnson & Johnson: protection begins after 14 days, while its effectiveness against the serious effects of COVID-19 disease, after 28 days, touches the 85%. After 49 days, the vaccine has been shown to almost completely prevent hospital admissions and the risk of death.